Detalhe da pesquisa
1.
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort).
EClinicalMedicine
; 28: 100591, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33078138